# GO_molecular_function_0064

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `GO_molecular_function`  
**Author expected answer:** **A** — O-methyltransferase activity

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MSTIRGTLSELSRAADAFAHEVDEAGYGDYTFLPDNSPFDLSFLTSKGLEARGSLIAAAEKILRLAKGPQGCLASFADTKGIEMGTIQALTQLEVPDKVPLQGSITYEELAGVIRVAPELLQRLVRLAALAGFLIEDESGAVRHTAMSAVFLRDTAAGDTARFLFDVDMRAYSFFADSLRLDPSGQNIGDGPTALAFQHDSDDQGNRPTIWDILERNPIQRARFHSTMQALGSFPSHLLKHILVAHDWHSIGSLVDVGGSLGHASLVIAENFPEIRITVQDLPDVVERGRSSLPTVPHAERVSFQAHDLFQEQAIIADAYFLRQILHDWPDGDAERIVRCLIPAMRPGAKLLIMDIVVPEPGAISPYMEKYLRTYDVSMFSMFSAKERTVQQLRDLVERCSARLQFQGISCPPGSATSLLSWVYSAE

[Multiple Choices]
A. O-methyltransferase activity
B. chromatin DNA binding
C. protein-membrane adaptor activity
D. lipid binding
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Molecular Function Prediction, which is to predict the fundamental activity of a protein at the molecular level, as defined by the Gene Ontology (GO) 'Molecular Function' branch. This describes the elemental tasks a protein performs, such as catalysis, transport, or binding to specific molecules. Based on the protein's amino acid sequence, you are to select the option that best describes its primary molecular function.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence matches the UniProt entry for FrzF. That entry reports O-methyltransferase activity and a specific methyl-transfer reaction, with evidence cited to a publication; this supports choice A. The separate GO annotation is computational (IEA:InterPro), not itself experimental evidence.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [H4](#evidence-h4), [H6](#evidence-h6).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is compatible with a soluble enzyme and makes chromatin-DNA binding or membrane-adaptor activity less immediately plausible, but that broad inference does not identify O-methyltransferase activity over other possible enzyme or binding functions.


**Missing item-specific fact**

> The protein-specific functional identification as FrzF and its demonstrated O-methylation of a phenolic oxygen are absent from the sequence-and-choices input.


**Reason**

> Choosing A requires an item-specific functional annotation, experimental result, or equivalent protein-specific knowledge. Generic sequence reasoning does not meaningfully establish this precise molecular activity.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The supplied evidence supports A; it does not support another listed option as a competing primary molecular function.


### Important caveats

- The cited experimental evidence is reported through UniProt and was not independently verified from the primary paper here.
- The reviewer-only accession and annotations establish expected-answer support but were not available to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is compatible with a soluble enzyme and makes chromatin-DNA binding or membrane-adaptor activity less immediately plausible, but that broad inference does not identify O-methyltransferase activity over other possible enzyme or binding functions.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific functional identification as FrzF and its demonstrated O-methylation of a phenolic oxygen are absent from the sequence-and-choices input.",
    "reason": "Choosing A requires an item-specific functional annotation, experimental result, or equivalent protein-specific knowledge. Generic sequence reasoning does not meaningfully establish this precise molecular activity."
  },
  "case_id": "GO_molecular_function_0064",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H3",
      "H4",
      "H6"
    ],
    "judgment": "supported",
    "reason": "The sequence matches the UniProt entry for FrzF. That entry reports O-methyltransferase activity and a specific methyl-transfer reaction, with evidence cited to a publication; this supports choice A. The separate GO annotation is computational (IEA:InterPro), not itself experimental evidence."
  },
  "important_caveats": [
    "The cited experimental evidence is reported through UniProt and was not independently verified from the primary paper here.",
    "The reviewer-only accession and annotations establish expected-answer support but were not available to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied evidence supports A; it does not support another listed option as a competing primary molecular function."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_molecular_function_0064",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence matches the UniProt entry for FrzF. That entry reports O-methyltransferase activity and a specific methyl-transfer reaction, with evidence cited to a publication; this supports choice A. The separate GO annotation is computational (IEA:InterPro), not itself experimental evidence.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H3", "H4", "H6"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is compatible with a soluble enzyme and makes chromatin-DNA binding or membrane-adaptor activity less immediately plausible, but that broad inference does not identify O-methyltransferase activity over other possible enzyme or binding functions.",
    "missing_item_specific_fact": "The protein-specific functional identification as FrzF and its demonstrated O-methylation of a phenolic oxygen are absent from the sequence-and-choices input.",
    "reason": "Choosing A requires an item-specific functional annotation, experimental result, or equivalent protein-specific knowledge. Generic sequence reasoning does not meaningfully establish this precise molecular activity."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied evidence supports A; it does not support another listed option as a competing primary molecular function."
  },
  "important_caveats": [
    "The cited experimental evidence is reported through UniProt and was not independently verified from the primary paper here.",
    "The reviewer-only accession and annotations establish expected-answer support but were not available to the evaluated model."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry A0A7T8J1Z8 (O-methyltransferase FrzF) is experimentally characterized (ECO:0000269, PubMed:33372776) as an O-methyltransferase that methylates the phenolic oxygen at C4 during FR901483 biosynthesis. The GO annotation GO:0008171 (O-methyltransferase activity) is assigned via IEA:InterPro, and the EC number 2.1.1.- is supported by experimental catalytic activity data showing methyl transfer from SAM to a phenolic hydroxyl. The sequence matches exactly (SHA256 confirmed).

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [C7](#evidence-c7), [C8](#evidence-c8), [H1](#evidence-h1), [H3](#evidence-h3), [H4](#evidence-h4), [H5](#evidence-h5), [H6](#evidence-h6), [GO1](#evidence-go1).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains a Rossmann-fold-like region with a SAM-binding glycine-rich motif (the 'VDVGGSLGHA' segment around residues ~200-215), which is a hallmark structural feature of class I methyltransferases. Among the four choices, only option A (O-methyltransferase activity) is a catalytic methyl-transfer function; the remaining options (chromatin DNA binding, protein-membrane adaptor activity, lipid binding) are binding/adaptor activities associated with entirely different domain architectures (zinc fingers, PH/C1/C2 domains, transmembrane segments, nuclear localization signals) that are absent from this sequence. A trained biologist recognizing the SAM-binding Rossmann motif and the absence of any DNA-binding, membrane-anchoring, or lipid-binding structural motifs would select the methyltransferase option.


**Missing item-specific fact**

> None critical. The specific 'O-' designation (vs N- or C-) is not independently derivable from sequence alone, but since only one methyltransferase option is offered, identifying the protein as a methyltransferase via the SAM-binding motif suffices to select A over the three non-catalytic alternatives.


**Reason**

> The SAM-binding Rossmann-fold motif is a well-known, generalizable feature of methyltransferases that can be recognized from sequence. The contrast with the three non-catalytic distractor options (which require entirely different domain types) is stark and does not depend on memorizing this specific protein's annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four options span mutually exclusive functional categories (catalysis vs DNA binding vs membrane adaptor vs lipid binding). The presence of a SAM-binding motif and absence of any DNA-binding, membrane-anchoring, or lipid-binding domains makes option A the only defensible choice. No ambiguity among options.


### Important caveats

- The GO:0008171 annotation is IEA:InterPro (computational inference), though the underlying protein function is experimentally validated by PubMed:33372776 (ECO:0000269).
- The specific 'O-' vs 'N-' vs 'C-' methyltransferase subclass designation relies on the experimental substrate specificity data, not purely on sequence motif recognition; however, since only one methyltransferase option is presented, this does not affect answer selection.
- The SAM-binding motif in this sequence ('VDVGGSLGHA') is somewhat degenerate relative to the canonical 'VIGGGxG' consensus, so motif recognition requires familiarity with the diversity of class I methyltransferase SAM-binding loops.
- The UniProt entry was first public in 2025-06-18; the benchmark's author source snapshot is unknown, though historical entry version 19 (released 2026-01) matches the sequence.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a Rossmann-fold-like region with a SAM-binding glycine-rich motif (the 'VDVGGSLGHA' segment around residues ~200-215), which is a hallmark structural feature of class I methyltransferases. Among the four choices, only option A (O-methyltransferase activity) is a catalytic methyl-transfer function; the remaining options (chromatin DNA binding, protein-membrane adaptor activity, lipid binding) are binding/adaptor activities associated with entirely different domain architectures (zinc fingers, PH/C1/C2 domains, transmembrane segments, nuclear localization signals) that are absent from this sequence. A trained biologist recognizing the SAM-binding Rossmann motif and the absence of any DNA-binding, membrane-anchoring, or lipid-binding structural motifs would select the methyltransferase option.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None critical. The specific 'O-' designation (vs N- or C-) is not independently derivable from sequence alone, but since only one methyltransferase option is offered, identifying the protein as a methyltransferase via the SAM-binding motif suffices to select A over the three non-catalytic alternatives.",
    "reason": "The SAM-binding Rossmann-fold motif is a well-known, generalizable feature of methyltransferases that can be recognized from sequence. The contrast with the three non-catalytic distractor options (which require entirely different domain types) is stark and does not depend on memorizing this specific protein's annotation."
  },
  "case_id": "GO_molecular_function_0064",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "C7",
      "C8",
      "H1",
      "H3",
      "H4",
      "H5",
      "H6",
      "GO1"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry A0A7T8J1Z8 (O-methyltransferase FrzF) is experimentally characterized (ECO:0000269, PubMed:33372776) as an O-methyltransferase that methylates the phenolic oxygen at C4 during FR901483 biosynthesis. The GO annotation GO:0008171 (O-methyltransferase activity) is assigned via IEA:InterPro, and the EC number 2.1.1.- is supported by experimental catalytic activity data showing methyl transfer from SAM to a phenolic hydroxyl. The sequence matches exactly (SHA256 confirmed)."
  },
  "important_caveats": [
    "The GO:0008171 annotation is IEA:InterPro (computational inference), though the underlying protein function is experimentally validated by PubMed:33372776 (ECO:0000269).",
    "The specific 'O-' vs 'N-' vs 'C-' methyltransferase subclass designation relies on the experimental substrate specificity data, not purely on sequence motif recognition; however, since only one methyltransferase option is presented, this does not affect answer selection.",
    "The SAM-binding motif in this sequence ('VDVGGSLGHA') is somewhat degenerate relative to the canonical 'VIGGGxG' consensus, so motif recognition requires familiarity with the diversity of class I methyltransferase SAM-binding loops.",
    "The UniProt entry was first public in 2025-06-18; the benchmark's author source snapshot is unknown, though historical entry version 19 (released 2026-01) matches the sequence."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options span mutually exclusive functional categories (catalysis vs DNA binding vs membrane adaptor vs lipid binding). The presence of a SAM-binding motif and absence of any DNA-binding, membrane-anchoring, or lipid-binding domains makes option A the only defensible choice. No ambiguity among options."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_molecular_function_0064",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry A0A7T8J1Z8 (O-methyltransferase FrzF) is experimentally characterized (ECO:0000269, PubMed:33372776) as an O-methyltransferase that methylates the phenolic oxygen at C4 during FR901483 biosynthesis. The GO annotation GO:0008171 (O-methyltransferase activity) is assigned via IEA:InterPro, and the EC number 2.1.1.- is supported by experimental catalytic activity data showing methyl transfer from SAM to a phenolic hydroxyl. The sequence matches exactly (SHA256 confirmed).",
    "evidence_ids": ["C4", "C5", "C6", "C7", "C8", "H1", "H3", "H4", "H5", "H6", "GO1"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains a Rossmann-fold-like region with a SAM-binding glycine-rich motif (the 'VDVGGSLGHA' segment around residues ~200-215), which is a hallmark structural feature of class I methyltransferases. Among the four choices, only option A (O-methyltransferase activity) is a catalytic methyl-transfer function; the remaining options (chromatin DNA binding, protein-membrane adaptor activity, lipid binding) are binding/adaptor activities associated with entirely different domain architectures (zinc fingers, PH/C1/C2 domains, transmembrane segments, nuclear localization signals) that are absent from this sequence. A trained biologist recognizing the SAM-binding Rossmann motif and the absence of any DNA-binding, membrane-anchoring, or lipid-binding structural motifs would select the methyltransferase option.",
    "missing_item_specific_fact": "None critical. The specific 'O-' designation (vs N- or C-) is not independently derivable from sequence alone, but since only one methyltransferase option is offered, identifying the protein as a methyltransferase via the SAM-binding motif suffices to select A over the three non-catalytic alternatives.",
    "reason": "The SAM-binding Rossmann-fold motif is a well-known, generalizable feature of methyltransferases that can be recognized from sequence. The contrast with the three non-catalytic distractor options (which require entirely different domain types) is stark and does not depend on memorizing this specific protein's annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options span mutually exclusive functional categories (catalysis vs DNA binding vs membrane adaptor vs lipid binding). The presence of a SAM-binding motif and absence of any DNA-binding, membrane-anchoring, or lipid-binding domains makes option A the only defensible choice. No ambiguity among options."
  },
  "important_caveats": [
    "The GO:0008171 annotation is IEA:InterPro (computational inference), though the underlying protein function is experimentally validated by PubMed:33372776 (ECO:0000269).",
    "The specific 'O-' vs 'N-' vs 'C-' methyltransferase subclass designation relies on the experimental substrate specificity data, not purely on sequence motif recognition; however, since only one methyltransferase option is presented, this does not affect answer selection.",
    "The SAM-binding motif in this sequence ('VDVGGSLGHA') is somewhat degenerate relative to the canonical 'VIGGGxG' consensus, so motif recognition requires familiarity with the diversity of class I methyltransferase SAM-binding loops.",
    "The UniProt entry was first public in 2025-06-18; the benchmark's author source snapshot is unknown, though historical entry version 19 (released 2026-01) matches the sequence."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A7T8J1Z8` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 19. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8J1Z8.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:52.176056+00:00.  

```json
"A0A7T8J1Z8"
```

Source SHA-256: `32ede02f32517874979e874842ff451de632a768dc1939171d1d3596a08918bd`.

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8J1Z8.json)  
**Locator:** `/entryAudit`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:52.176056+00:00.  

```json
{"entryVersion":21,"firstPublicDate":"2025-06-18","lastAnnotationUpdateDate":"2026-09-02","lastSequenceUpdateDate":"2021-06-02","sequenceVersion":1}
```

Source SHA-256: `32ede02f32517874979e874842ff451de632a768dc1939171d1d3596a08918bd`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8J1Z8.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:52.176056+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"FR901483 biosynthesis cluster protein F"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"value":"2.1.1.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"O-methyltransferase FrzF"}}}
```

Source SHA-256: `32ede02f32517874979e874842ff451de632a768dc1939171d1d3596a08918bd`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8J1Z8.json)  
**Locator:** `/comments/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:52.176056+00:00.  

```json
{"commentType":"FUNCTION","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"value":"O-methyltransferase; part of the gene cluster that mediates the biosynthesis of the alkaloid (-)-FR901483, a potent immunosuppressant that shows efficacy in animal models and a probable inhibitor of purine nucleotide biosynthesis by targeting phosphoribosylpyrophosphate amidotransferase (PPAT) (PubMed:33372776). Within the pathway, FrzF methylates the phenolic oxygen at position C4 (PubMed:33372776). The biosynthesis of (-)-FR901483 starts with the condensation of two L-tyrosines to yield (S,S)-dityrosyl-piperazine. This process occurs in 3 steps with the non-canonical nonribosomal peptide synthetase FrzA catalyzing the reduction of L-tyrosine into L-tyrosinal, the spontaneous condensation of 2 L-tyrosinal units, and the subsequent reduction by the NmrA-like family domain-containing oxidoreductase FrzB. The cytochrome P450 monooxygenase FrzC then performs coupling between N10 and C1' to morph the piperazine into a 1,4-diazabicyclo[3.2.1]octane spiro-fused to a 2,5-cyclohexadienone. The dienone portion is further reduced to cyclohexanone by the flavin-dependent reductase FrzD. The methyltranserases (MTs) FrzE and FrzF are then involved in the methylation at the C10' amine and the C4 phenolic oxygen, respectively. The order of the two MTs appear to be interchangeable. Cleavage of the C9-N10' bond by the dioxygenase FrzG then leads to formation of a conjugated iminium. In addition to the oxidation of C9, an additional dehydrogenation between C7 and C8 can occur to give a likely shunt product. The next biosynthetic step is the intramolecular aldol condensation catalyzed by the newly identified aldolase FrzH to yield an aza-tricyclic product with the formation of a C9-C3' bond (PubMed:33372776). The short-chain dehydrogenase/reductase FrzI then produces dephospho-(-)-FR901483 that is phosphorylated at C4'-OH into (-)-FR901483 by the phosphotransferase FrzJ (PubMed:33372776)"}]}
```

Source SHA-256: `32ede02f32517874979e874842ff451de632a768dc1939171d1d3596a08918bd`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8J1Z8.json)  
**Locator:** `/comments/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:52.176056+00:00.  

```json
{"commentType":"CATALYTIC ACTIVITY","physiologicalReactions":[{"directionType":"left-to-right","evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"reactionCrossReference":{"database":"Rhea","id":"RHEA:83592"}}],"reaction":{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"name":"(1S,4S)-4-[(4-hydroxyphenyl)methyl]-2,5-diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-4'-one + S-adenosyl-L-methionine = (1S,4S)-4-[(4-methoxyphenyl)methyl]-2,5-diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-4'-one + S-adenosyl-L-homocysteine + H(+)","reactionCrossReferences":[{"database":"Rhea","id":"RHEA:83591"},{"database":"ChEBI","id":"CHEBI:15378"},{"database":"ChEBI","id":"CHEBI:57856"},{"database":"ChEBI","id":"CHEBI:59789"},{"database":"ChEBI","id":"CHEBI:233175"},{"database":"ChEBI","id":"CHEBI:233177"}]}}
```

Source SHA-256: `32ede02f32517874979e874842ff451de632a768dc1939171d1d3596a08918bd`.

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8J1Z8.json)  
**Locator:** `/comments/2`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:52.176056+00:00.  

```json
{"commentType":"CATALYTIC ACTIVITY","physiologicalReactions":[{"directionType":"left-to-right","evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"reactionCrossReference":{"database":"Rhea","id":"RHEA:83596"}}],"reaction":{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"name":"(1S,4S)-4-[(4-hydroxyphenyl)methyl]-2-methyl-2,5-diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-4'-one + S-adenosyl-L-methionine = (1S,4S)-4-[(4-methoxyphenyl)methyl]-2-methyl-2,5-diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-4'-one + S-adenosyl-L-homocysteine + H(+)","reactionCrossReferences":[{"database":"Rhea","id":"RHEA:83595"},{"database":"ChEBI","id":"CHEBI:15378"},{"database":"ChEBI","id":"CHEBI:57856"},{"database":"ChEBI","id":"CHEBI:59789"},{"database":"ChEBI","id":"CHEBI:233176"},{"database":"ChEBI","id":"CHEBI:233178"}]}}
```

Source SHA-256: `32ede02f32517874979e874842ff451de632a768dc1939171d1d3596a08918bd`.

### Evidence C8

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8J1Z8.json)  
**Locator:** `/uniProtKBCrossReferences/3`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:52.176056+00:00.  

```json
{"database":"GO","id":"GO:0008171","properties":[{"key":"GoTerm","value":"F:O-methyltransferase activity"},{"key":"GoEvidenceType","value":"IEA:InterPro"}]}
```

Source SHA-256: `32ede02f32517874979e874842ff451de632a768dc1939171d1d3596a08918bd`.

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8J1Z8?format=txt&versions=19)  
**Locator:** `lines 1-13`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 19 / 1.  
**Retrieved:** 2026-11-02T04:25:54.122159+00:00.  

```text
ID   FRZF_CLASX              Reviewed;         427 AA.
AC   A0A7T8J1Z8;
DT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.
DT   02-JUN-2021, sequence version 1.
DT   28-JAN-2026, entry version 19.
DE   RecName: Full=O-methyltransferase FrzF {ECO:0000303|PubMed:33372776};
DE            EC=2.1.1.- {ECO:0000269|PubMed:33372776};
DE   AltName: Full=FR901483 biosynthesis cluster protein F {ECO:0000303|PubMed:33372776};
GN   Name=FrzF {ECO:0000303|PubMed:33372776};
OS   Cladobotryum sp.
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;
OC   Hypocreomycetidae; Hypocreales; Hypocreaceae; Cladobotryum.
OX   NCBI_TaxID=2040732;
```

Source SHA-256: `b04f01db868e607e76a98568774abea21dd993afd1fc87f063a28fcc2ed40a7b`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8J1Z8?format=txt&versions=19)  
**Locator:** `lines 23-51`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 19 / 1.  
**Retrieved:** 2026-11-02T04:25:54.122159+00:00.  

```text
CC   -!- FUNCTION: O-methyltransferase; part of the gene cluster that mediates
CC       the biosynthesis of the alkaloid (-)-FR901483, a potent
CC       immunosuppressant that shows efficacy in animal models and a probable
CC       inhibitor of purine nucleotide biosynthesis by targeting
CC       phosphoribosylpyrophosphate amidotransferase (PPAT) (PubMed:33372776).
CC       Within the pathway, FrzF methylates the phenolic oxygen at position C4
CC       (PubMed:33372776). The biosynthesis of (-)-FR901483 starts with the
CC       condensation of two L-tyrosines to yield (S,S)-dityrosyl-piperazine.
CC       This process occurs in 3 steps with the non-canonical nonribosomal
CC       peptide synthetase FrzA catalyzing the reduction of L-tyrosine into L-
CC       tyrosinal, the spontaneous condensation of 2 L-tyrosinal units, and the
CC       subsequent reduction by the NmrA-like family domain-containing
CC       oxidoreductase FrzB. The cytochrome P450 monooxygenase FrzC then
CC       performs coupling between N10 and C1' to morph the piperazine into a
CC       1,4-diazabicyclo[3.2.1]octane spiro-fused to a 2,5-cyclohexadienone.
CC       The dienone portion is further reduced to cyclohexanone by the flavin-
CC       dependent reductase FrzD. The methyltranserases (MTs) FrzE and FrzF are
CC       then involved in the methylation at the C10' amine and the C4 phenolic
CC       oxygen, respectively. The order of the two MTs appear to be
CC       interchangeable. Cleavage of the C9-N10' bond by the dioxygenase FrzG
CC       then leads to formation of a conjugated iminium. In addition to the
CC       oxidation of C9, an additional dehydrogenation between C7 and C8 can
CC       occur to give a likely shunt product. The next biosynthetic step is the
CC       intramolecular aldol condensation catalyzed by the newly identified
CC       aldolase FrzH to yield an aza-tricyclic product with the formation of a
CC       C9-C3' bond (PubMed:33372776). The short-chain dehydrogenase/reductase
CC       FrzI then produces dephospho-(-)-FR901483 that is phosphorylated at
CC       C4'-OH into (-)-FR901483 by the phosphotransferase FrzJ
CC       (PubMed:33372776). {ECO:0000269|PubMed:33372776}.
```

Source SHA-256: `b04f01db868e607e76a98568774abea21dd993afd1fc87f063a28fcc2ed40a7b`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8J1Z8?format=txt&versions=19)  
**Locator:** `lines 52-61`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 19 / 1.  
**Retrieved:** 2026-11-02T04:25:54.122159+00:00.  

```text
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(1S,4S)-4-[(4-hydroxyphenyl)methyl]-2,5-
CC         diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-4'-one + S-adenosyl-
CC         L-methionine = (1S,4S)-4-[(4-methoxyphenyl)methyl]-2,5-
CC         diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-4'-one + S-adenosyl-
CC         L-homocysteine + H(+); Xref=Rhea:RHEA:83591, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:233175,
CC         ChEBI:CHEBI:233177; Evidence={ECO:0000269|PubMed:33372776};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:83592;
CC         Evidence={ECO:0000269|PubMed:33372776};
```

Source SHA-256: `b04f01db868e607e76a98568774abea21dd993afd1fc87f063a28fcc2ed40a7b`.

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8J1Z8?format=txt&versions=19)  
**Locator:** `lines 62-71`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 19 / 1.  
**Retrieved:** 2026-11-02T04:25:54.122159+00:00.  

```text
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(1S,4S)-4-[(4-hydroxyphenyl)methyl]-2-methyl-2,5-
CC         diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-4'-one + S-adenosyl-
CC         L-methionine = (1S,4S)-4-[(4-methoxyphenyl)methyl]-2-methyl-2,5-
CC         diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-4'-one + S-adenosyl-
CC         L-homocysteine + H(+); Xref=Rhea:RHEA:83595, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:233176,
CC         ChEBI:CHEBI:233178; Evidence={ECO:0000269|PubMed:33372776};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:83596;
CC         Evidence={ECO:0000269|PubMed:33372776};
```

Source SHA-256: `b04f01db868e607e76a98568774abea21dd993afd1fc87f063a28fcc2ed40a7b`.

### Evidence H6

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8J1Z8?format=txt&versions=19)  
**Locator:** `lines 84-84`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 19 / 1.  
**Retrieved:** 2026-11-02T04:25:54.122159+00:00.  

```text
DR   GO; GO:0008171; F:O-methyltransferase activity; IEA:InterPro.
```

Source SHA-256: `b04f01db868e607e76a98568774abea21dd993afd1fc87f063a28fcc2ed40a7b`.

### Evidence GO1

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)  
**Locator:** `lines 80302-80313`  
**Scope:** current ontology; exact historical benchmark ontology unknown.  
**Retrieved:** 2026-11-01T07:04:24.975173+00:00.  

```text
[Term]
id: GO:0008171
name: O-methyltransferase activity
namespace: molecular_function
def: "Catalysis of the transfer of a methyl group to the oxygen atom of an acceptor molecule." [GOC:ai]
xref: Reactome:R-HSA-5578717 "BCDIN3D dimethylates 5' phosphate of pre-miR-145"
xref: Reactome:R-HSA-5629203 "HENMT1 methylates 2' hydroxyl at 3' end of piRNA in 4xMeR-PIWIL1:piRNA:TDRD6:TDRKH"
xref: Reactome:R-HSA-5629218 "HENMT1 methylates 2' hydroxyl at 3' end of piRNA in 6xMeR-PIWIL2:piRNA:TDRD1:TDRD12:DDX4:ASZ:MOV10L1"
xref: Reactome:R-HSA-5629237 "HENMT1 methylates 2' hydroxyl at 3' end of piRNA in MeR-PIWIL4:piRNA:TDRD9:MAEL:TDRKH"
xref: Reactome:R-HSA-6790907 "Box C/D snoRNP methylates ribonucleotides in pre-rRNA yielding 2'-O-methylribonucleotides"
is_a: GO:0008168 ! methyltransferase activity

```

Source SHA-256: `b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_molecular_function.json), zero-based source row 64. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
